Enhancing Sensorimotor Processing in Children With Dystonia

NCT ID: NCT05612464

Last Updated: 2022-11-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-01

Study Completion Date

2028-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dystonia is a severely disabling movement disorder with no cure, in which people suffer painful muscle spasms causing twisting movements and abnormal postures. There are many causes, including genetic conditions and brain injury. The most common cause in childhood is dystonic cerebral palsy (CP) which often affects the whole body.

The underlying mechanisms are unknown, but there is growing evidence to implicate abnormal brain processing by the brain of incoming "sensory" information (e.g., signals to the brain from our senses of touch and body position): the distorted perception of these signals disrupts the way the brain produces instructions for planning and performing movements.

The investigator's previous studies have shown that the way the brain processes sensory information related to movement is abnormal in children with dystonia and dystonic CP, by using methods that record the EEG (electroencephalogram - brain wave signals) and/or EMG (electromyogram - electrical signal from muscles). A specific brain rhythm (called mu) typically shows well-defined changes in response to movement, and reflects processing of sensory information. The investigator's work shows these rhythm changes are abnormal in children with dystonia/dystonic CP.

This study will explore if these findings can improve treatment. In particular the study team will investigate whether children and young people with dystonia/dystonic CP can enhance these mu rhythm responses during a movement task by using feedback of their brain rhythms displayed as a cartoon/game on a computer. The investigators will also assess whether enhanced mu activity is associated with improved movement control. This would open future possibilities to use such devices for therapy/rehabilitation.

Children and young people with dystonia/dystonic CP aged 5-25 years will be recruited, along with age-matched controls. Studies will last 2-3 hours with time for breaks and will be conducted at Evelina London Children's Hospital and Barts Health Trust, with the option for home visits if preferable for families.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dystonic Cerebral Palsy Dystonia, Secondary Dystonia Dystonia, Primary Dystonia; Idiopathic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Primary dystonia group (genetic or idiopathic)

No intervention

Intervention Type OTHER

No intervention

Dystonic cerebral palsy group

No intervention

Intervention Type OTHER

No intervention

Control group

No intervention

Intervention Type OTHER

No intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

No intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Control Group:

* Age 5 -25 years
* No known disorder of movement
* Able to understand and participate in study.

Primary dystonia group (isolated genetic or idiopathic):

* Age 5-25 years
* Clinical dystonia - as confirmed on clinical assessment by consultant paediatric neurologist.
* Genetic or idiopathic aetiology.
* No other neurological abnormality.
* Normal cranial magnetic resonance imaging (MRI).
* Able to understand and participate in study.

Dystonic Cerebral Palsy Group:

* Age 5-25 years
* Clinical dystonia/dyskinesia - as confirmed on clinical assessment by consultant paediatric neurologist.
* Documented history of perinatal hypoxic-ischaemic encephalopathy (HIE), prematurity \<35 weeks or kernicterus.
* Predominant dystonia/dyskinesia / Minimal spasticity
* MRI findings in keeping with acute perinatal HIE, prematurity or kernicterus (including classical pattern of damage to thalami, basal ganglia and peri-rolandic cortex, periventricular leukomalacia or ischaemic parenchymal injury).
* Able to understand and participate in study.

Exclusion Criteria

Control Group:

* Age \<5 or \>25 years
* Any known disorder of movement.

Primary dystonia group (isolated genetic or idiopathic):

* Age \< 5 or \>25 years
* Presence of other neurological abnormality in addition to dystonia.
* Abnormal cranial MRI.

Dystonic Cerebral Palsy Group:

* Age \< 5 or \>25 years
* No clear history of perinatal HIE, prematurity or kernicterus.
* Predominant spasticity.
* MRI scan not compatible with perinatal HIE, prematurity or kernicterus
Minimum Eligible Age

5 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Guy's and St Thomas' NHS Foundation Trust

OTHER

Sponsor Role collaborator

Barts & The London NHS Trust

OTHER

Sponsor Role collaborator

Imperial College London

OTHER

Sponsor Role collaborator

University of Bristol

OTHER

Sponsor Role collaborator

University of Calgary

OTHER

Sponsor Role collaborator

King's College London

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

317454

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.